Penn Medicine Provider
Endocrine and Oncologic Surgery
Robert E. Roses, MD
4.9
(411)
Accepting new patients
Sees patients age 18 and up
Penn Endocrine and Oncologic Surgery Perelman 3rd Floor
View 1 additional location
Make an appointmentCall 800-789-7366

About me

  • Professor of Surgery at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Tufts University School of Medicine
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: University of Texas - MD Anderson Cancer Center

What my patients think about me

Average Rating
4.9

411 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
high quality care
April 2025
5.0
5.0
dr roses is what you want in a doctor. knowledgeable, caring and thoughtful.
April 2025
5.0
5.0
he is very through
April 2025
5.0
5.0
he is very good at what he does and i am confident in his knowledge and skills.

Insurance accepted

My Locations

Learn about location
Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Lancaster General Hospital: Has privileges to treat patients in the hospital.
Dr. Roses is a Penn Medicine physician.

Qualifications and experience

My research

Concors SJ, Roses RE, Paulson EC ASO Author Reflections: Hepatectomy and proctectomy for metastatic rectal cancer: Is a combined approach best for all patients? , Annals of Surgical Oncology, 26(12): 2019,3980-3981

Maggino L, Malleo G, Bassi C, Allegrini V, Beane JD, Beckman RM, Chen B, Dickson EJ, Drebin JA, Ecker BL, Fraker DL, House MG, Jamieson NB, Javed AA, Kowalsky SJ, Lee MK, McMillan MT, Roses RE, Salvia R, Valero V 3rd, Velu LKP, Wolfgang CL, Zureikat AH, Vollmer CM Jr Identification of an optimal cut-off for drain fluid amylase on postoperative day 1 for predicting clinically relevant fistula after distal pancreatectomy: A multi-institutional analysis and external validation , Annals of Surgery, 269(2): 2019,337-343

Concors SJ, Sinnamon AJ, Ecker BL, Metz DC, Vollmer CM, Fraker DL, Roses RE The impact of surgery for metastatic pancreatic neuroendocrine tumor: A contemporary evaluation matching for chromogranin a level , HPB, 22(1): 2020,83-90

Seykora TF, Maggino L, Malleo G, Lee MK 4th, Roses R, Salvia R, Bassi C, Vollmer CM Jr. Evolving the paradigm of early drain removal following pancreatoduodenectomy , Journal of Gastrointestinal Surgery, 23(1): 2019,135-144

Concors SJ, Vining CM, Saur NM, Roses RE, Paulson EC Combined proctectomy and hepatectomy for metastatic rectal cancer should be undertaken with caution: Results of a national cohort study , Annals of Surgical Oncology, 26(12): 2019,3972-3979

Wachtel H, Bhandari S, Roses RE, Cohen DL, Trerotola SO, Fraker DL Primary aldosteronism with nonlocalizing imaging , Surgery, 165(1): 2019,211-218

Kumar S, Katona BW, Long JM, Domchek S, Rustgi AK, Roses R, Ginsberg GG Endoscopic ultrasound has limited utility in diagnosis of gastric cancer in carriers of CDH1 mutations , Clinical Gastroenterology & Hepatology, 18(2): 2020,505-508.e1

Maggino L, Malleo G, Bassi C, Allegrini V, McMillan MT, Borin A, Chen B, Drebin JA, Ecker BL, Fraker DL, Lee MK, Paiella S, Roses RE, Salvia R, Vollmer CM Jr Decoding grade B pancreatic fistula: A clinical and economical analysis and subclassification proposal , Annals of Surgery, 269(6): 2019,1146-1153

Azari FS, Roses RE Management of early stage gastric and gastroesophageal junction malignancies , Surgical Clinics of North America, 99(3): 2019,439-456

Folkert IW, Roses RE ASO Author Reflections: Revisiting risk of dissemination from small rectal neuroendocrine tumors , Annals of Surgical Oncology, 27(3): 2020,864-865